RAC1 and neoplasm: Our results indicated that targeting inhibition or down-regulation of CD36 in LUAD cells significantly reduced tumor cell proliferation and metastasis, in which Src-Akt/Erk signaling and Rac1 activation-induced actin remodeling were involved.